REVIEWED COMPANY
BioAge Labs
Clinical-stage biotechnology research targeting the biology of human aging
What BioAge Labs does
BioAge Labs is a clinical-stage biopharmaceutical company researching potential medicines for cardiometabolic diseases by studying the biology of human aging. Its discovery platform uses human longevity data to identify biological pathways for drug development. The company advances investigational candidates through preclinical research and clinical studies. BioAge Labs is publicly traded on Nasdaq under the symbol BIOA.